CepacolSore Throat (Reckitt Benckiser LLC)


Welcome to the PulseAid listing for the Cepacol drug offered from Reckitt Benckiser LLC. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Reckitt Benckiser LLC
NON-PROPRIETARY NAME: Dyclonine Hydrochloride and Glycerin
SUBSTANCE NAME: DYCLONINE HYDROCHLORIDE; GLYCERIN
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: LIQUID
MARKETING CATEGORY NAME: OTC MONOGRAPH NOT FINAL
START MARKETING DATE: 2011-05-20
END MARKETING DATE: 0000-00-00


Cepacol Sore Throat HUMAN OTC DRUG Details:

Item DescriptionCepacol Sore Throat from Reckitt Benckiser LLC
LABELER NAME: Reckitt Benckiser LLC
DEA SCHEDULE:
ACTIVE STRENGTH: .1; 33(g/100mL; g/100mL)
START MARKETING DATE: 2011-05-20
END MARKETING DATE: 0000-00-00
PRODUCT ID: 63824-781_1823aecf-9e1f-4029-bf89-2c454ee9a9b0
PRODUCT NDC: 63824-781
APPLICATION NUMBER: part356

Other DYCLONINE HYDROCHLORIDE; GLYCERIN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Reckitt Benckiser LLCCepacol